Company Filing History:
Years Active: 2011-2014
Title: Jesper Grarup: Innovator in Pain Management
Introduction
Jesper Grarup is a notable inventor based in Roskilde, Denmark. He has made significant contributions to the field of pain management through his innovative work on fentanyl compositions. With a total of 3 patents, Grarup's inventions focus on improving the administration and efficacy of pain relief medications.
Latest Patents
Grarup's latest patents include a groundbreaking fentanyl composition for nasal administration. This invention addresses the treatment of acute pain by allowing for intranasal administration of fentanyl. The method results in a time to onset of action that is comparable to intravenous administration, while also providing a significantly faster onset than nasal titration of fentanyl. Notably, the nasal administration of a sufficient dosage leads to lower maximum plasma concentrations, which are comparable to intravenous administration. This innovation also results in reduced rates of adverse events, such as respiratory depression, nausea, and vomiting. Compositions for use in this method are also disclosed in his patents.
Career Highlights
Throughout his career, Jesper Grarup has worked with prominent companies in the pharmaceutical industry. He has been associated with Nycomed Danmark Aps and Takeda Pharma A/S, where he has contributed to the development of innovative pain management solutions.
Collaborations
Grarup has collaborated with notable colleagues, including Hanne Wulf Nielsen and Hanne Wulff Nielsen. Their teamwork has likely played a role in advancing the research and development of pain relief technologies.
Conclusion
Jesper Grarup's contributions to the field of pain management through his innovative fentanyl compositions highlight his role as a significant inventor. His work continues to impact the way acute pain is treated, showcasing the importance of innovation in healthcare.